Viz™ LVO
AI software detection of large vessel occlusion stroke on...
Background Artificial intelligence (AI) software is increasingly applied in stroke diagnostics. However, the actual performance of AI tools for identifying...
Jan 27, 2022
Viz.ai Collaborates with Microsoft Read the Announcement
Life Sciences
Discover how we work with life sciences partners to drive patient care innovation.
Artificial Intelligence–Parallel Stroke Workflow Tool Improves Reperfusion Rates and Door-In to Puncture Interval
The Viz.ai artificial intelligence (AI) software module Viz large‐vessel occlusion (LVO) utilizes AI‐powered LVO detection and triage technology to automatically identify suspected LVOs through computed tomographic angiogram imaging and alert on‐call stroke teams. We performed this analysis to determine whether the Viz LVO software can reduce the door‐in to puncture time interval within a comprehensive stroke center (CSC) for patients requiring endovascular treatment.
We conducted a retrospective chart review that compared the time interval between patient arrival in the emergency department (door‐in) to puncture for patients who presented consecutively with a stroke code to our CSC between November 2016 and May 2020. The implementation of the AI software (Viz LVO) at the CSC was in November 2018. Using a prospectively collected database at the CSC, demographics, and outcomes were examined. This study was based on evaluating real‐world practice.
We analyzed 86 patients from the pre‐AI study phase (average age, 68.53±13.13 years, 40.7% female) and 102 patients from the post‐AI study phase (average age, 69.87±15.75 years, 43.1% women). Following the implementation of the software, the mean door‐in to puncture time interval within the CSC significantly improved by 86.7 minutes (206.6 versus 119.9 minutes; P<0.001); significant improvements were also noted in the rate of reperfusion (modified Thrombolysis in Cerebral Infraction 2B‐3) for patients in the post‐AI population (P=0.036).
The incorporation of the software was associated with a significant improvement in treatment time within the CSC, as well as significantly higher rates of adequate reperfusion. Prospective, multicenter, controlled studies with a larger cohort are warranted to expand on the ability of Viz LVO to improve treatment times and outcomes for patients with an LVO stroke.
Researcher:
Ameer Hassan , DO, FAHA, FSVIN
Publication:
Date Published: September 7, 2022
Sep 07, 2022
Viz™ LVO
Background Artificial intelligence (AI) software is increasingly applied in stroke diagnostics. However, the actual performance of AI tools for identifying...
Jan 27, 2022
Viz™ LVO
Background Emergent large vessel occlusion (ELVO) acute ischemic stroke is a time-sensitive disease. Objective To describe our experience with artificial...
Aug 20, 2021
Viz™ LVO
Background Viz.ai artificial intelligence (AI) software utilizes AI powered large vessel occlusion (LVO) detection technology which automatically identifies suspected LVO...
Mar 11, 2021
Schedule a meeting
Experience the power of AI
See for yourself how you can harness the power of AI to accelerate patient access to care through AI-powered care coordination.